NCT05393908

Brief Summary

The aim of this study is to perform a randomized trial to investigate if intraoperative surgeon administered TAP block reduces pain and use of oral and parenteral pain medications after repeat cesarean delivery. The investigators aim to compare surgeon administered TAP block with liposomal bupivacaine compared to standard treatment (i.e. no TAP block) with regard to the primary outcome of post-operative narcotic use.

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
14mo left

Started Jan 2026

Typical duration for not_applicable postoperative-pain

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Jan 2026Jun 2027

First Submitted

Initial submission to the registry

May 18, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 26, 2022

Completed
3.6 years until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

12 months

First QC Date

May 18, 2022

Last Update Submit

November 12, 2024

Conditions

Keywords

Cesarean delivery, post-operative pain, TAP block

Outcome Measures

Primary Outcomes (1)

  • Daily Narcotic Use in Morphine Equivalents

    Daily Narcotic Use in Morphine Equivalents

    From time of surgery through postpartum day 4

Secondary Outcomes (5)

  • Time to first administered narcotic (oral or parental)

    From time of surgery through postpartum day 4

  • Daily Average Pain Score

    From time of surgery through postpartum day 4

  • Daily Maximum Pain Score

    From time of surgery through postpartum day 4

  • Time to First Ambulation

    From time of surgery through postpartum day 4

  • Time to First Solid Food

    From time of surgery through postpartum day 4

Study Arms (2)

TAP Block Group

ACTIVE COMPARATOR

Participants will receive a surgeon administered TAP block consisting of liposomal bupivacaine during their repeat cesarean delivery.

Procedure: TAP Block Group

Standard of Care Postoperative Pain Control

NO INTERVENTION

Participants will not receive a surgeon administered TAP block consisting of liposomal bupivacaine during their repeat cesarean delivery and will receive the routine standard of care for post-operative pain control.

Interventions

Participants will receive a surgeon administered TAP block.

TAP Block Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women presenting for elective repeat cesarean delivery at 37-42 weeks gestational age.
  • Pregnancy and delivery care obtained at UMass Memorial Medical Center
  • Patients able to provide written informed consent
  • English, Spanish, or Portuguese-speaking patients

You may not qualify if:

  • Participants who are under the age of 18 years
  • Active labor.
  • Baseline pain score \> 6.
  • Unable to provide informed consent.
  • Prisoners will be excluded from this research.
  • Narcotic use in the 2 weeks prior to delivery.
  • Active substance abuse.
  • Inability to take narcotic analgesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Wilson RD, Caughey AB, Wood SL, Macones GA, Wrench IJ, Huang J, Norman M, Pettersson K, Fawcett WJ, Shalabi MM, Metcalfe A, Gramlich L, Nelson G. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1). Am J Obstet Gynecol. 2018 Dec;219(6):523.e1-523.e15. doi: 10.1016/j.ajog.2018.09.015. Epub 2018 Sep 18.

    PMID: 30240657BACKGROUND
  • Tsai HC, Yoshida T, Chuang TY, Yang SF, Chang CC, Yao HY, Tai YT, Lin JA, Chen KY. Transversus Abdominis Plane Block: An Updated Review of Anatomy and Techniques. Biomed Res Int. 2017;2017:8284363. doi: 10.1155/2017/8284363. Epub 2017 Oct 31.

    PMID: 29226150BACKGROUND
  • Kupiec A, Zwierzchowski J, Kowal-Janicka J, Gozdzik W, Fuchs T, Pomorski M, Zimmer M, Kubler A. The analgesic efficiency of transversus abdominis plane (TAP) block after caesarean delivery. Ginekol Pol. 2018;89(8):421-424. doi: 10.5603/GP.a2018.0072.

    PMID: 30215460BACKGROUND
  • Abdallah FW, Halpern SH, Margarido CB. Transversus abdominis plane block for postoperative analgesia after Caesarean delivery performed under spinal anaesthesia? A systematic review and meta-analysis. Br J Anaesth. 2012 Nov;109(5):679-87. doi: 10.1093/bja/aes279. Epub 2012 Aug 19.

    PMID: 22907337BACKGROUND
  • Kwikiriza A, Kiwanuka JK, Firth PG, Hoeft MA, Modest VE, Ttendo SS. The analgesic effects of intrathecal morphine in comparison with ultrasound-guided transversus abdominis plane block after caesarean section: a randomised controlled trial at a Ugandan regional referral hospital. Anaesthesia. 2019 Feb;74(2):167-173. doi: 10.1111/anae.14467. Epub 2018 Nov 1.

    PMID: 30383289BACKGROUND
  • Mishriky BM, George RB, Habib AS. Transversus abdominis plane block for analgesia after Cesarean delivery: a systematic review and meta-analysis. Can J Anaesth. 2012 Aug;59(8):766-78. doi: 10.1007/s12630-012-9729-1. Epub 2012 May 24.

    PMID: 22622954BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Gianna Wilkie, MD

    University of Massachusetts Chan Medical School

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 18, 2022

First Posted

May 26, 2022

Study Start

January 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 30, 2027

Last Updated

November 14, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share